BRANDON RHODES: Open Payments
NPI 1225423544 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 33 payments from 9 companies in 2025. Trend: 2023 $255 · 2024 $849 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $156 |
| Novartis Pharmaceuticals Corporation | 6 | $146 |
| Merck Sharp & Dohme LLC | 7 | $139 |
| Novo Nordisk Inc | 7 | $132 |
| ABIOMED | 2 | $95 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $31 |
| ABBVIE INC. | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $14 |
Products named: LEQVIO, VERQUVO, Wegovy, JOT DX, CARDIOMEMS, LifeVest, UPTRAVI, CAPVAXIVE.
Industry payments across TX — which companies pay providers there.
